Frontiers in Oncology (Aug 2024)

Editorial: The role of post-translational modifications in cancer biology

Swati Srivastava,
Anurag Tripathi,
Anurag Tripathi,
Arun Kumar Trivedi,
Arun Kumar Trivedi

Affiliations

Swati Srivastava: Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India
Anurag Tripathi: Food Toxicology Group, CSIR- Indian Institute of Toxicology Research, Lucknow, India
Anurag Tripathi: Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India
Arun Kumar Trivedi: Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India
Arun Kumar Trivedi: Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India

DOI: https://doi.org/10.3389/fonc.2024.1470173
Journal volume & issue: Vol. 14

Abstract

No abstracts available.

Published in Frontiers in Oncology

ISSN: 2234-943X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.frontiersin.org/journals/oncology/

About the journal